THE CLINICAL SCENARIO
A 54-year-old obese male labourer requires an elective thoraco-abdominal procedure for curable oesophageal malignancy. His cardiac clinical risk factors include diabetes mellitus, chronic renal impairment, hypertension and hypercholesterolaemia. He has good functional capacity with no cardiorespiratory symptoms. Preoperative cardiopulmonary exercise testing reveals an anaerobic threshold of 20 ml/min/kg. The patient predictors (diabetes mellitus and chronic renal impairment) for cardiovascular disease that independently increase perioperative risk. The preoperative stress thallium test is arranged to further stratify the patient's perioperative cardiovascular risk. The result is positive for the presence of silent reversible myocardial ischaemia. Given the patient's lack of cardiac symptoms, good functional capacity and a known false positive rate for stress thallium testing, should he be advised to undergo conventional diagnostic coronary angiography, with the attendant risks that include cerebral vascular events (0.3%), coronary artery or graft dissection (0.1%), trauma to arterial cannulation site with pseudo-aneurysm formation (1.2%), cardiac arrhythmias (1%), angina (0.2%), myocardial infarction (0.2%), renal failure (secondary to embolic disease or contrast material) and even death? 1 Should he proceed directly to SUMMARY Multislice computed tomography coronary angiography is emerging as a reliable non-invasive method for the assessment of coronary artery disease, coronary anatomy and cardiac function. Improvements in computed tomography technology hold the promise of replacing the standard invasive procedure of conventional coronary angiography in selected patient groups. The ability of a six-second scan to identify flow-limiting coronary artery stenoses as well as characterising coronary atheromatous plaque components provides valuable information that can assist in refining perioperative cardiovascular risk. Multislice computed tomography's high negative predictive value and high specificity for stenoses allows it to effectively rule out coronary artery disease in patients with cardiac risk factors who have non-diagnostic or equivocal non-invasive cardiac stress tests. Other uses include evaluating patients who are symptomatic following percutaneous coronary intervention, evaluating coronary artery bypass grafts and coronary stent patency, detecting coronary stenosis prior to valve surgery and assessing coronary anatomy in patients with technically difficult arterial access. Avoiding the small but definite risks of conventional coronary angiography makes cardiac computed tomography an appealing alternative. An overview of multislice computed tomography is presented with particular attention placed on its role in the risk stratification of selected patients in the perioperative period. A risk stratification algorithm is suggested.
INTRODUCTION
Determining patients' cardiac risk is a major focus of effective preoperative evaluation. The American College of Cardiology (ACC) and the American Heart Association (AHA) guidelines on perioperative cardiovascular evaluation and care for patients undergoing noncardiac surgery advocate a stepwise strategy for determining perioperative cardiac risk that relies on the assessment of patient clinical risk factors, functional capacity and surgery-2 . Independent clinical risk factors for increased perioperative cardiac morbidity and mortality include a history of coronary artery disease (CAD), heart failure, diabetes mellitus,
The current ACC/AHA guidelines advocate that patients undergoing a low-risk surgical procedure can proceed to planned surgery without further cardiac evaluation. Similarly, the guidelines advocate that all patients with a good functional capacity can proceed directly to planned surgery risk. Non-invasive cardiac risk evaluation is only recommended for patients with a poor or unknown functional capacity who have one or more clinical risks factors who are undergoing vascular or intermediate risk surgery.
The ACC/AHA guidelines do not advocate with good functional capacities that have multiple cardiovascular clinical risks (e.g. chronic renal cerebrovascular disease), even if they are undergoing surgical procedures include major vascular or thoraco-abdominal surgery and any anticipated prolonged surgical procedure associated with in the elderly. Assessment of functional capacity based only on questions that assess capacity for activities of daily living has inherent limitations. The assessment of functional capacity should be based on objective measurement and seen in the context of the nature and severity of underlying In this review, the perioperative use of MSCT with particular reference to its role in cardiac risk algorithm that can be used in conjunction with the well-known ACC/AHA guidelines is presented.
WHAT IS MSCT CORONARY ANGIOGRAPHY?
MSCT is a reliable, non-invasive method for the assessment of coronary artery disease, coronary anatomy and cardiac function. The ability of a six-second scan to perform a comprehensive cardiac evaluation make cardiac risk in selected patients. Computed tomography (CT) of the heart has been technically challenging due to the continuous motion of the heart. Recent technical advances in multi-detector row CT, together with electrocardiographic (ECG)synchronised scanning and reconstruction, now allow for both a high spatial and an improved temporal resolution image 4, 5 . These improvements have resulted in thinner slices that are essential for the visualisation of cardiac anatomy and a reduction in motion-associated artefacts: as less time is required to acquire an image, there is a smaller chance for vessel movement. To further reduce cardiac motion artefacts, MSCT images are reconstructed during periods of minimal cardiac movement. A single breath-hold is used to eliminate respiratory motion artefacts. Currently, 64-row detector scanners allow a comprehensive cardiac evaluation to be completed in less than six seconds.
To differentiate the vessel's lumen from its wall, intravascular contrast is injected via a peripheral vein, which allows angiographic evaluation of the coronary arteries' lumens and characterisation of the coronary arteries' walls. The diameter of coronary vessels decreases from 5 mm in the left main coronary artery down to 1 mm in the distal left anterior descending coronary artery 6 . Interactive three-dimensional re-formation software is used to analyse the coronary tree in longitudinal and cross-sectional planes. Three-dimensional volume-rendered images facilitate the assessment of spatial orientation. However, at present, the temporal and spatial resolution of MSCT is still less than that of conventional angiography. Computed tomography can be used to evaluate cardiac function and heart valves, yet for these applications, noninvasive imaging modalities such as echocardiography are generally preferred. Therefore, the principal diagnostic value of cardiac pathology of the coronary arteries and evaluating the severity of CAD. It is in this regard that MSCT may emerge as an important tool to assist in the undergoing surgery.
CLINICAL APPLICATIONS OF MSCT IN THE PERIOPERATIVE PERIOD
In clinical situations where a high likelihood conventional coronary angiography (CCA) provides luminal stenosis. The high spatial and temporal resolution of CCA guides the interventional and stenotic coronary lesions. However, in other clinical situations, the comprehensive assessment of obstructive and non-obstructive CAD may increasingly rely on MSCT. A comparison of MSCT and CCA is summarised in Table 1 . The clinical applications of MSCT in the perioperative period are outlined below.
Demonstration of coronary anatomy
One advantage of MSCT over CCA is that cardiac structures can be demonstrated in three dimensions ( Figure 1 ). An important clinical differentiation is that between stenotic atherosclerotic CAD and coronary arteries with anomalous origin and/or course in relationship to the aorta and pulmonary arterial trunk. This information is of clinical importance because, for example, the demonstration of an anomalous artery tracking between the aorta and the pulmonary artery may indicate the need for surgical correction. Figure 2 shows an aberrant origin of the left main coronary artery and its passage between the aorta and pulmonary artery. Additional nonatherosclerotic coronary abnormalities detectable by MSCT angiography include the intramyocardial course of a coronary artery due to a myocardial bridge and aneurysmally dilated coronary arteries with or without thrombi. 
Identification of occlusive coronary artery disease
The capability of MSCT to detect obstructive CAD increases in reliability as the number of detectors increases. Recent studies demonstrate that MSCT obstructive CAD 7 . Figures 3 and 4 present images of the normal coronary circulation acquired with 64-slice CT technology. The reported diagnostic accuracy of the older 16-slice CT varies between studies with reported sensitivities and positive and negative predictive values (NPV) of 90 to 100% [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . The improved image quality of current 64-slice CT technology allows for greater diagnostic accuracy even in unselected patient populations.
to be over 90%, 94%, 89% and 95%, respectively [26] [27] [28] [29] [30] [31] [32] [33] [34] . It is important to note that all studies that used 64-slice CT consistently demonstrate high excellent form of investigation for excluding coronary artery stenosis. In selected patient groups, MSCT may therefore become an acceptable alternative to invasive CCA 7 .
Many acute coronary syndromes are initiated by sudden changes of mildly stenotic lesions rather than from progression of lesions that are causing [35] [36] [37] of mildly stenotic but vulnerable atherosclerotic lesions and the overall plaque burden could provide better markers of coronary risk than measurements of luminal stenosis 38 . One of the major advantages of MSCT over CCA is the potential for assessing atherosclerotic plaque morphology. Plaque composition can be differentiated into soft and thus prone to rupture, resulting in an acute coronary syndrome 39 . It is in this regard that MSCT is emerging as a useful non-invasive means of plaques 40, 41 . The assessment of plaque characteristics may have an important role in identifying patients who are at greater perioperative cardiovascular risk. Figure 5 demonstrates the ability of MSCT coronary arteries, the presence of soft plaques and obstructive CAD.
Multislice CT has also been used in the assessment of coronary arteries prior to valve surgery 22, 42, 43 . Conventional coronary angiography is routinely performed before valve replacement surgery for acquired valvular disease. However, a recent study evaluated the predictive values of MSCT in the to valve surgery in patients with severe valvular disease without known CAD and compared this to CCA 22 . The sensitivity for the detection of NPV was 99%. A normal MSCT in this setting is exclusion of CAD without the need for invasive procedures. The main cause of false positive and negative results or non-assessable coronary Nonetheless, the results of this study demonstrate evaluation of CAD in selected patients undergoing valvular heart surgery. Further studies are needed before MSCT can become an accepted tool in the cardiac workup of such patients.
Another role that MSCT may have in the preoperative period is the detection of CAD in patients with left bundle branch block (LBBB). The presence of LBBB correlates strongly with age and indicates an increased risk for cardiac mortality [44] [45] [46] [47] [48] [49] [50] [51] . In myocardial infarction, acute LBBB is related to ischaemia in the territory of the left anterior descending coronary artery, but chronic LBBB is a clinical predictor of atherosclerotic CAD. In patients with LBBB who present for major surgery, it is important to determine the extent of CAD in order to stratify the risk and manage therapy 44 . Of particular relevance in the preoperative period, noninvasive stress testing has limited value in patients with complete LBBB, since ST-segment interpreted as ischaemia [52] [53] [54] [55] [56] . In patients with LBBB, myocardial perfusion studies often demonstrate false positive perfusion defects in the anteroseptal/ septal territory 53, 54 . Although dobutamine stress moderately sensitive for septal ischaemia in patients with abnormal septal thickening. Conventional coronary angiography is therefore frequently with complete LBBB. A 64-slice CT scan may also patients with complete LBBB. Studies evaluating the accuracy of 64-slice CT in identifying CAD in patients with complete LBBB reported sensitivity, 97%, respectively 44 . Therefore, a normal MSCT in invasive procedures. such as those with previous surgery of the femoral arteries or patients with previous complications from invasive CCA, for example, false aneurysm formation, MSCT is a valuable non-invasive tool to assess the coronary circulation. A negative MSCT of CAD without the need for invasive CCA.
Coronary artery graft patency assessment
MSCT is emerging as a reliable non-invasive method for visualising coronary artery bypass graft (CABG) patency and detecting bypass graft stenoses. Invasive CCA is the gold standard for the direct assessment of bypass graft patency; however, several small studies have investigated the potential of MSCT as a non-invasive alternative [57] [58] [59] [60] [61] . The patency and stenosis have been consistently high when compared to CCA. Multislice CT coronary angiography has been shown to detect bypass graft occlusion with almost 100% sensitivity 62 . Advances in MSCT reconstruction algorithms combined with ECG-gated imaging now allow for an accurate assessment of patent or stenotic bypass graft vessels ( Figure 6 ). Atherosclerotic changes at coronary bypass anastamoses can also be evaluated in greater detail. Three-dimensional imaging offers the ability to view the anastamoses from multiple angles (Figure 7 ). This may assist in the preoperative planning of patients undergoing revision CABG by offering the cardiac surgeon an accurate assessment of vessel stenosis and demonstrating the course of native coronary arteries, grafts and the internal mammary arteries, which need to be avoided during sternotomy 63 . Limitations of MSCT for graft assessment occur in the presence of surgical clips, particularly when evaluating mammary artery bypass grafts and can lead to impaired visualisation of the arterial grafts and their distant anastamoses. The close proximity of the internal mammary bypass graft stenoses 64 .
Assessment of coronary stent patency
Percutaneous coronary intervention has become an accepted method of treating patients with CAD. However, in-stent stenosis attributable to intimal hyperplasia still occurs at a relatively high rate with both bare metal and drug eluting stents 65, 66 . Invasive CCA remains the gold standard in the assessment of in-stent stenosis. However, because of risks associated with CCA, the application of MSCT to assess the patency of the stented arterial segment is rapidly developing 64, 67, 68 . Current MSCT technology, in combination with optimal heart rate control, allows reliable non-invasive evaluation of selected patients following coronary artery stenting. MSCT has both high accuracy for the detection of assessing stent patency of up to 100%, making it an excellent tool to exclude in-stent stenosis 26, 27, [69] [70] [71] . MSCT has also been shown to be safe in excluding left main coronary artery in-stent stenosis and has to CCA in selected patients 72 . Multislice CT is evolving as an alternative to routine CCA for the planning and follow-up of percutaneous coronary intervention, particularly in the assessment of stent patency. Limitations to the use of MSCT, however, surrounds the stent and metallic artefacts. Both can impair the quality of the images of the implanted stent.
Evaluation of left ventricular function and perfusion
In the perioperative period, the assessment of global left and right ventricular function, ventricular in the evaluation of patients with CAD undergoing major surgical procedures. These parameters therapeutic strategy, appropriate level of monitoring and perioperative prognosis. Two-dimensional echocardiography will remain the standard perioperative investigation in this regard. However, MSCT can be used to assess global and regional left ventricular function and left ventricular volumes (Figures 8 and 9 ). Data acquisition is gated to the electrocardiogram allowing left ventricular function and volume to be derived from a single data set. Studies show excellent correlations between MSCT and 2D-echocardiography for the assessment of left ventricular end-diastolic volume, left ventricular end-systolic volume, ejection fraction and regional wall motion [73] [74] [75] [76] . Although based on small clinical trials, MSCT can also be used to evaluate perfusion defects in patients with previous myocardial infarction 75, 76 reduced perfusion. When compared with gated single-photon emission computed tomography, MSCT detected perfusion defects correctly in 93% of the segments. In addition, MSCT did not detect any perfusion defects in 98% of the segments with normal perfusion on single-photon emission computed tomography.
THE CARDIAC CALCIUM SCORE AND ITS ROLE IN PERIOPERATIVE RISK STRATIFICATION
Computed tomography without intravascular contrast enhancement can be used for coronary using one of several calcium scoring algorithms. FIGURE 8: Assessment of ejection fraction, muscle mass and regional wall motion. Images acquired with a 64-slice CT using automated surface mapping of myocardial inner and outer margins in a short axis view from the base of heart to the apex. FIGURE 9: A 64-slice CT demonstrating three-dimensional representation of ventricular wall and cavity in diastole and systole, assessing regional wall motion and ventricular volumes.
Since coronary artery calcium deposition occurs exclusively as a result of atherosclerosis, any detectable calcium is regarded as predictor of CAD. A calcium score of zero is normal, while abnormal scores range as high as several hundreds. The calcium score provides no information concerning individual occlusive CAD. This technique does not determine whether the plaque is stable (with a low likelihood of coronary adverse events) or unstable (with a high likelihood of events). It also poses the greatest risk for adverse events. The incremental value of coronary calcium scanning, in addition to the conventional Framingham risk factors, such as family history of CAD, diabetes, hypertension, smoking, hyperlipidaemia and obesity, still needs to be further elucidated in the perioperative period. At present, the Cardiac Society of Australia and New Zealand considers that available evidence supports risk assessment based on conventional risk factors alone 77 . The detection little additional information to help in cardiac risk
MSCT FOR PERIOPERATIVE RISK STRATIFICATION IN MAJOR NON-CARDIAC SURGERY
MSCT is a useful non-invasive method to determine the contribution of CAD to perioperative cardiac risk in selected patient groups. Multislice CT should not be used in patients who have active unstable coronary syndromes, decompensated heart heart disease 2 and require further investigation and management prior to any surgery in order to reduce perioperative risk. Likewise, MSCT has little role in the risk in patients with good functional capacity that have less than three cardiovascular clinical risks (e.g. failure, cerebrovascular disease or CAD). The use of cardiac stress testing for the purpose of diagnosing CAD in asymptomatic patients has been criticised 3 . Finally, it is critical to exclude CAD as the cause a poor functional capacity in patients scheduled for intermediate or high-risk surgery as the combination of poor functional capacity and myocardial ischaemia is associated with higher perioperative mortality 79, 80 . If CAD is considered to be a contributory factor for a poor functional capacity, non-invasive stress testing should be advocated. In cases where CAD is not believed to be the cause of poor functional capacity, other modes of investigation may be appropriate, for example, echocardiography for the evaluation of ventricular and valvular function, or the evaluation of Patients with a positive non-invasive stress can be considered for MSCT. A negative MSCT is consistent with a low risk of occlusive perioperative CAD and this precludes the need for consideration of conventional cardiac angiography, although there are no studies to prove this. Patients with a positive MSCT should be considered for CCA only if this will change management. Again, these patients can of perioperative beta-blockade, invasive cardiac monitoring and postoperative intensive or high dependency care. The current challenge is to determine whether using MSCT in the perioperative period will modify perioperative management and avoid cardiovascular complications. 
In contrast, in patients with

LIMITATIONS OF MSCT CORONARY ANGIOGRAPHY
The two main limitations of MSCT include the obscuring of coronary arteries due to extensive of the heart. Electrocardiography monitoring reduces motion artefacts by gating data acquisition during mid-diastole. The ideal heart rate is 60 beats/min but heart rates up to 75 beats/min give adequate quality images. Beta-blockers can be administered to slow the heart and provide a greater time for image acquisition. A short breath-hold and the requirement for regular rhythm are also preferable. The limitation regarding the requirement for a slow rate is overcome by advanced technology of dual source and 256-slice CT imaging technology, which allows for heart rates up to 110 beats/min without affecting image quality. The metal stents and clips remain the main limitation of the technique. Metal clips placed alongside bypass grafts, especially internal mammary artery grafts can cause artefacts. However, compared with previous scanner generations, 64-slice CT technology allows for more reliable evaluation of grafts and native coronary arteries in patients after bypass surgery.
The relatively high radiation dose received with MSCT compared to CCA cannot be ignored. The effective radiation dose of CCA ranges from 2 to 5 mSv [81] [82] [83] , whereas the radiation received with MSCT varies from approximately 5 to 16 mSv for 16-slice CT to between 7 and 12 mSv for 64-slice CT 84, 85 . This is equivalent to the background cosmic radiation exposure to any individual who lives in a major city over a period of six to 10 years 64 . However, the latest innovation in CT cardiac scan technology allows innovative, advanced cardiac imaging utilising prospective ECG scanning; X-ray is only emitted during a short phase of the heart cycle. This advanced improvement reduces the radiation dose to about 1 to 4 mSv or by about 70%, without compromising image quality.
Practical limitations of routine 64-slice CT use include the initial costs of the hardware and software, together with the appropriate radiological support systems required. This needs to be weighed against the limitations of invasive CCA, in particular the inherent procedural risks, the need for multiple staff members including a cardiologist, nursing staff and a cardiac technologist, and the costs incurred during the procedure and the ensuing observational period. As with CCA, MSCT also requires the administration of contrast medium, making contrast nephropathy a potential but uncommon complication. Finally, compared with CCA, MSCT is unable to accurately coronary circulation and across stenotic lesions 64 .
SUMMARY
Multislice CT is a relatively new imaging modality capable of diagnosing or excluding CAD, assessing patency of bypass grafts and stents and assessing the characteristics of atherosclerotic plaques. The integrated assessment of coronary anatomy, regional and global left ventricular function and perfusion with MSCT is an evolving technique that has considerable potential for the preoperative evaluation of patients undergoing major surgery. The axiom mandates a cardiological review is no longer true. Invasive CCA, which is regarded as the gold standard in detecting CAD, is being challenged by the introduction of MSCT to evaluate CAD. The capability to avoid invasive angiography may compel the anaesthetist and perioperative clinician to use MSCT in selected patients. This potential development means that anaesthetists should MSCT technology. There is no direct evidence at present evaluating whether the use of MSCT in the perioperative period will avoid cardiovascular complications. Further studies are required to assess of patients undergoing non-cardiac surgery. Departments embracing this new technology will need to critically review the number of patients with positive non-invasive stress tests who are referred for MSCT and whether MSCT in reality changes perioperative management. Clinical audit evaluating whether MSCT will avoid invasive interventions such as CCA and its cost-effectiveness will need to be undertaken. Unnecessary cancellations/delays in surgery, improved patient care and the avoidance of perioperative cardiovascular complications will also need to be systematically reviewed. In the interim, it is anticipated that future generations of MSCT will have even better spatial and temporal resolutions and hence improved diagnostic accuracy.
